Both parties have symbiotic relationships with profiteers that stifle progress and innovation.
Both parties have symbiotic relationships with profiteers that stifle progress and innovation.
I heard all about this, and so did lots of people. It was as well covered as anything is these days.
Second, health care experts don't seem to think much of the new rules, since there's little evidence anyone price shops for care, especially since, regardless of published prices, they're not the ones paying for them; they pay indirectly, through premiums. I think price transparency is a good thing and the rule is a good thing, but I don't think this is "huge".
Third, the "obvious reasons" snark at the end of your comment poisons what would otherwise have been a valuable contribution to the thread.
I suggest the obvious reason this new regulation doesn’t get as much press attention as you’d like has less to do with Trump and more to do with its futility.